News

FDA Requiring Stronger Safety Labels for Opioid Medications
By Stephanie Brown HealthDay ReporterMONDAY, Aug. 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration announced ...
US FDA names Sean Keveney as chief counsel
The U.S. Food and Drug Administration on Monday named Sean Keveney as its new chief counsel, placing him in charge of ...
Medscape7h
FDA Approves VIZZ Eye Drops to Treat Presbyopia
The FDA has approved VIZZ eye drops (LENZ Therapeutics, Inc.) for the treatment of presbyopia, the gradual loss of near ...
FDA Issues Highest Risk Warning For Nuts
Navarro Pecan Holdings, LLC issued a voluntary recall of 32,670 pounds of pecan products on July 10 due to concerns about ...
Nationwide honey recall update as FDA issues risk warning
The FDA 's classification of the Queen Bee Gardens recall as Class II signals a moderate health risk, indicating that use or ...
FDA upgrades nationwide butter recall alert to a higher level
( NewsNation) — The Food and Drug Administration (FDA) has escalated a recent nationwide recall of 64,800 pounds of butter to ...
WSJ Opinion: A Shakeup at the FDA
U.S. swimmers hear the criticism, even as they finish on top at worlds Tesla just announced a $29 billion pay package for ...
FDA Issues Nationwide Class II Recall on 32 Tons of Butter
The same butter was recalled earlier in July, but only designated as a Class III.
FDA vaccine chief leaving agency after less than 3 months
Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure ...
FDA's top vaccine official leaves agency after controversial decisions
Dr. Vinay Prasad, an oncologist who was a fierce critic of COVID vaccine and mask mandates, was appointed in May.
FDA’s Reversal on Gene Therapy Helps My Son
Parents of boys with Duchenne muscular dystrophy weigh in on drug innovation and medical regulation.
Controversial vaccine official Dr. Vinay Prasad departs FDA
Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...